Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • COF vs GSK✓SelectedUSD · GSKCOF vs GSK performance historyLatest closeAs of-0.95%11/16
Stock and ETF performance explorer

COF vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+5,146.5%
GSK return
+924.9%
Excess return
+4,221.5%
Maximum drawdown
-90.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.0%-0.1%-0.9%-0.9%
7D-2.7%-1.3%-1.4%-2.1%
30D-4.2%+2.7%-7.0%-5.8%
3M-14.7%+2.7%-17.4%-16.4%
6M+4.0%+3.3%+0.7%+1.2%
YTD-19.3%+6.5%-25.8%-23.3%
1Y-7.1%+10.7%-17.7%-13.4%
3Y+91.6%+64.4%+27.3%+38.0%
5Y+36.7%+46.7%-10.0%+1.8%
10Y+185.1%+109.4%+75.8%+71.8%
All+5,146.5%+924.9%+4,221.5%+1,878.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling